newsfilter
← Latest News
GlobeNewswire·

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

VANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) -- Absci (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the appointment of